Frazier Life Sciences
- United States
- Canada
- Europe
- Seed
- Series A
- Series B
- Biotech
Frazier Life Sciences (part of Frazier Healthcare Partners) is a biotech VC based in Seattle, leading highly curated investments in therapeutics with significant track record in creating and scaling firms.
Investment Thesis
Team
Albert Cha, M.D., Ph.D. – Managing Partner; James N. Topper, M.D., Ph.D. – Managing Partner; Patrick Heron – Managing Partner; Daniel Estes, Ph.D. – General Partner; James W. Brush, M.D. – General Partner & Portfolio Manager; Anna H. Chen, Ph.D. – Partner; Aditya Kohli, Ph.D. – Partner; Joe Cabral – Principal; Kevin Li, M.D. – Principal; Lin Mu, M.D., MBA – Vice President; Angel Martin, Ph.D. – Senior Associate; Jason Wang – Senior Associate; Kiah Williams, M.D. – Senior Associate; Xinghuo Li, Ph.D. – Associate; Chris Wittenborn – Trader; Gordon Empey – Chief Operating Officer, General Counsel and Partner; Ali Jackson – Vice President and Counsel, Public Funds; Ailsa Dalgliesh, Ph.D. – Head of Investor Relations; Kei Nakazono – IT Director; Shu Yeung – Director, Human Resources; Adam Simpson – Venture Partner; James Li, M.D. – Venture Partner; Maria Fardis, Ph.D. – Venture Partner; Mitch Gold, M.D. – Venture Partner; Robert Hershberg, M.D., Ph.D. – Venture Partner; Stanford Peng, M.D., Ph.D. – Venture Partner; Tao Fu, M.D., Ph.D. – Venture Partner; Azmi Nabulsi, M.D., M.P.H. – Entrepreneur‑in‑Residence; Brian Farmer – Entrepreneur‑in‑Residence; Chris Peetz – Entrepreneur‑in‑Residence; Gordon McMurray, Ph.D. – Entrepreneur‑in‑Residence; Ian W. Mills, B.M., B.CH., D.M. – Entrepreneur‑in‑Residence; Scott Byrd – Entrepreneur‑in‑Residence; Lauren Mifflin, Ph.D. – Principal of Company Creation; Christopher Aakre, Ph.D. – Principal of Company Creation; Zaneta Odrowaz, Ph.D. – Vice President of Company Creation; Alan Frazier – Chairman Emeritus; Angie You, Ph.D. – Senior Advisor; Bhaskar Chaudhuri, Ph.D. – Senior Advisor; Scott Wasserman, M.D. – Venture Partner; James Li, M.D. – Venture Partner
Portfolio
Arcutis Biotherapeutics
Phathom Pharmaceuticals
Lengo Therapeutics
Amunix Pharmaceuticals
Acerta Pharma
Krystal Biotech
Chinook Therapeutics
Sierra Oncology